OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Advisory Board and Contents	241
Advisory Board and Contents	232
Subscription and Copyright Information	232
Subscription and Copyright Information	211
Advisory Board and Contents	203
The right drug at the right time: key to IBD success	160
Subscription and Copyright Information	134
Subscription and Copyright Information	131
m6A and beyond: RNA modifications shaping angiogenesis	128
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	125
Beneath the radar: immune-evasive cell sources for stroke therapy	113
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	105
Muscle-to-CNS signaling in physiological homeostasis, aging, and disease	101
Lymph node microenvironment rewires ferroptosis redox defenses	99
Microbiota: a dawn for cancer metastasis therapy	98
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	94
Consideration of the importance of measuring thermal discomfort in biomedical research	93
d-Amino acids: new clinical pathways for brain diseases	90
Opportunities and challenges for biomarker discovery using electronic health record data	89
Fc-optimized checkpoint antibodies for cancer immunotherapy	87
Neutrophils and extracellular traps in crystal-associated diseases	85
Pushing the boundaries of brain organoids to study Alzheimer’s disease	78
Microbes and mood: innovative biomarker approaches in depression	77
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	77
Hormesis as an adaptive response to infection	76

Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	74
Advisory Board and Contents	69
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	68
Brain-specific regulatory T cell expansion limits cognitive decline	68
Engineering cytokines for tumor-targeting and selective T cell activation	67
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients	64
Erythropoietic protoporphyrias: updates and advances	63
Epigenetic regulation in intervertebral disc degeneration	62
Molecular mechanisms in the pathogenesis of dengue infections	61
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments	59
Is endometriosis a progressive disease?	55
Amyloid and collagen templates in aortic valve calcification	54
Insights from HIV-1 vaccine and passive immunization efficacy trials	54
Emerging roles of cyclin-dependent kinase 7 in health and diseases	54
Keratinocytes: new perspectives in inflammatory skin diseases	53
Acquired resistance to immunotherapy in solid tumors	53
Subscription and Copyright Information	53
Three ‘E’ challenges for siRNA drug development	53
Subscription and Copyright Information	53
Advisory Board and Contents	52
Roadmap for developing biologically inspired therapeutics for genetic brain disorders	52
Subscription and Copyright Information	51
Shining a light on comorbidities	51
Tick-borne encephalitis: emerging clinical trends and challenges	48
Significant challenges to translating breakthrough science in Mexico	48
SOX17: escape route from immune destruction in early CRC	48